Journal Article Summary
The article discusses a rare case of toxic epidermal necrolysis (TEN) occurring in a pregnant woman undergoing treatment for recurrent implantation failure (RIF) with hydroxychloroquine (HCQ). RIF is a condition where multiple in vitro fertilization (IVF) attempts fail despite using good quality embryos. Understanding the potential side effects of medications like HCQ, which is often prescribed for immune-related issues, is crucial, especially during pregnancy, as it can lead to severe skin reactions that may require immediate medical attention.
The study presents the case of a 36-year-old pregnant woman who developed painful and itchy skin lesions after starting HCQ treatment prior to her embryo transfer. Upon her visit to the emergency department, it was determined that more than 30% of her body surface area was affected, leading to a diagnosis of TEN. After discontinuing HCQ and administering appropriate treatments, including intravenous immunoglobulins and topical medications, her condition improved significantly within three days, and she was discharged in good health, later delivering healthy twins via cesarean section.
Despite the positive outcome, the article acknowledges limitations, such as the potential for recall bias regarding the patient's medical history. It emphasizes the importance of monitoring for rare adverse reactions to medications like HCQ, particularly in pregnant patients, to prevent serious complications. Readers are encouraged to discuss any concerns about medication side effects and treatment options with their healthcare providers to ensure safe and effective care.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Ghasemi Tehrani Hatav, Zakerinasab Faezeh, Khalili Geshnigani Negar, Rahmati Rahem, Zamani Dehkordi Nastaran. Toxic Epidermal Necrolysis and Recurrent Implantation Failure: Unveiling a Rare Phenomenon During Pregnancy. Clinical Case Reports 2025. DOI: 10.1002/ccr3.71226. PMID: 41090042. PMCID: PMC12516148.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg — 300 Count Bottle — Generic For Claritin — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
